Major Pharmaceutical Company Calls Back a Range of Children’s Allergy and Cold Products
Key Takeaways:
- A major pharmaceutical company has issued a recall on over 40 children’s allergy and cold medications over potential discrepancies with federal quality standards.
- The recall includes well-known brands such as Benadryl, Motrin, Zyrtec, and Tylenol Plus and affects the US market and 11 other countries.
- Reasons for the recall include the presence of active ingredients that are more concentrated than specified, inactive compounds that fail to meet testing standards or products containing particulates or other substances failing internal requirements.
- The company has cooperated with the FDA to ensure consumer safety and has urged parents and caregivers to stop using these medication immediately.
- This is not a standalone incident for the company, as they had previous recalls earlier this year related to complaints of moldy scents among over-the-counter drugs.
A substantial recall of over 40 children’s allergy and cold remedies was recently initiated by a prominent pharmaceutical company. This is due to potential discrepancies with federal quality standards in some of their cough and allergy liquid medications.
The list of voluntarily pulled products includes well-known brands such as Benadryl, Motrin, Zyrtec, and Tylenol Plus. According to the organization, these offerings have been available in the US market as well as 11 other countries.
Reasons Behind the Recall Initiative
The company emphasizes the absence of adverse medical incidents as the driving reason behind this recall. However, as a proactive measure, they urge parents and caregivers to stop administering these particular products to children.
The initiative stems from the fact that some of the recalled products may contain an active ingredient that is more concentrated than specified. In contrast, some may have inactive compounds that fail to meet the required testing standards. There may also be products containing particulates or other inactive substances failing to meet internal testing requirements.
The Role of the FDA in This Matter
The company cooperated closely with the United States Food and Drug Administration (FDA) to come to the decision of this recall. The FDA’s priority is that consumers stop employing these drugs immediately and understand actions they can take if they have concerns related to any specific product.
According to Dr. Margaret A. Hamburg, FDA Commissioner of Food and Drugs, “Americans deserve medications that are safe, effective, and of the highest quality. Although the chance for severe health concerns is minimal, we are investigating the products and facilities related to this recall and will continue to provide updates as we find out more.”
Previous Instances of Recall
Reports suggest that this is not a stand-alone incident for the company. Earlier this year, various products were recalled following complaints of moldy scents among over-the-counter drugs produced in a Puerto Rican-based factory. Specific batches of Benadryl, Motrin, Rolaids, Simply Sleep, St. Joseph Aspirin, and Tylenol were encompassed by that recall.
For More Information
An exhaustive list of the recalled products can be found by visiting the official website of the pharmaceutical company in question.
